SPONSORED

Chelsea Clinton speaks out against Cannabis

In a rare interview the daughter of the former president claims that marihuana does kill people.

•• 3 Min
Chelsea Clinton speaks out against Cannabis

Former White House Rugrat Chelsea Clinton believes marijuana can have some therapeutic benefits, but she also thinks the herb can kill people in states where it was made legal. During a recent appearance at Youngstown State University, Clinton - campaigning on behalf of her mother, Democratic presidential candidate Hillary Clinton - told a crowd of students that "anecdotally, we have a lot of evidence" that cannabis is effective in treating epilepsy and stimulates the appetite of those undergoing chemotherapy treatment. But she then went on to say that there are still some public health concerns associated with weed consumption due to the recent deaths in Colorado. "We also now have anecdotal evidence from Colorado where some of the people who used marijuana for these purposes, the coroner believe after they died, there was drug interactions with other things they used," she said. While there is no documented evidence that marijuana has ever contributed to the death of a single person in the thousands of years it has been used by civilizations around the world, prohibitionists often dig deep into their sagging propaganda bags to try to get the average person off convince that the effects of cannabis can be both devastating and deadly. But this is the first time we've heard of marijuana potentially interacting with other drugs and leading people to their premature demise. A recent article on InhaleMD points out that while there may be some minor interactions when cannabis is consumed in conjunction with other drugs and foods, there is no evidence that these types of mixtures can be fatal. "Cannabis is not known to cause lethal interactions with other substances, including food and beverages," the article said. "In fact, compared to natural and synthetic drugs, cannabis is exceptionally gentle, with negative effects typically limited to anxiety, dry mouth, increased thirst \[and\] sore throat." The article penned by Dr. Jordan Tishler, an expert in cannabis medicine, goes on to explain that while marijuana is "not physically harmful," when mixed with alcohol, antidepressants, antihistamines, and muscle relaxants, the effects of stone can often be enhanced - which Makes the user feel more intoxicated or in a deeper state of relaxation. But it does not appear that anyone died as a direct result of mixing marijuana with other drugs, as Clinton seems to have suggested in her speech over the weekend. Using marijuana in combination with other substances is "much safer than mixing most other types of medication," the article continued. However, Chelsea Clinton took the opportunity to reiterate her mother's stance on states rights and the prosecution of more medical marijuana research. But, their comments, once again, seemed to imply that marijuana might be what the federal government claims - a dangerous drug. "We just need so much more data than we have so that people who might benefit have a chance to benefit, people who might be at risk are protected," Clinton said. "So absolutely, my mom strongly supports the need for more rigorous study and then subjecting it, like we kind of do anything else that might have a medical purpose, to get FDA approval, testing and ultimately regulation." Hillary Clinton has said for most of her campaign that she plans to remove cannabis from List I if she is elected president in November.

CannabisMedicineElections

Most Popular News

  1. SpaceX’s $8B Spectrum Deal Sends AT&T, Verizon, and T-Mobile Plummeting
  2. Is Project Vault Securing America’s Supply Chain or Squeezing It to the Breaking Point?
  3. Why Gautam Lohia Shifted from Global Consulting to Reboot a $20M Tech Micro-Cap
  4. Everyday Luxury, Unstoppable Scale: Aritzia Delivers 44% Net Revenue Growth
  5. Can Navy SEAL Leadership and Big Tech Scale Revolutionize Airborne Threat Detection?

Disclaimer


This report should not be viewed as investment advice or as an offer to buy or sell any securities or as an invitation or solicitation of an offer to buy or sell any securities. Neither the author of this report, its publisher, nor any other person associated with the publication of this report, are registered brokers, investment dealers, investment advisers, or financial advisers. The information in this report has not been tailored to the particular needs or circumstances of readers and should not be relied upon as investment advice or recommendations to purchase or sell any of the securities presented in this report. Readers seeking investment advice should contact qualified and registered brokers, investment dealers, investment advisers, or financial advisers prior to making any decision to buy or sell any of the securities referred to in this report. The information in this report should not be construed as investment, legal, or tax advice. No recommendation is made as to whether an investment in the presented securities is suitable for any reader in light of the reader’s particular circumstances.

Readers are cautioned that the publisher of this report covers exclusively securities that carry a high degree of volatility. Investing in such securities is highly speculative and carries a high degree of risk. Investors in such securities could lose all or a substantial portion of their investment. Only those investors who can afford to lose all or a substantial portion of their investment should consider investing in the securities referred to in this report.

This report may include information obtained from publicly available sources, including third-party reports or analysis. Neither the author nor publisher of this report, nor www.juniorstocks.com or its owners, have undertaken any independent investigation into the factual information used in this report, and the information in this report is provided without any warranty of any kind. No representations or warranties are provided regarding the accuracy or completeness of the information provided in this report. Statements of opinion or belief are those of the authors and/or publisher of this report. These statements of opinion or belief are expressions of the author’s and/or publisher’s judgment, and there is no guarantee that those judgments will turn out to be correct. No inference should be drawn that the author and/or publisher have any special or greater knowledge about the presented companies or their securities, or any particular expertise in the industries or markets in which the company operates. Readers should conduct their own due diligence and seek professional advice prior to investing in any securities presented on Juniorstocks.com.

Certain statements in this report constitute “forward-looking” statements. Forward-looking statements often, but not always, are identified by the use of words such as “seek,” “anticipate,” “believe,” “plan,” “estimate,” “expect,” “targeting,” and “intend” and statements that an event or result “may,” “will,” “should,” “could,” or “might” occur or be achieved and other similar expressions. Forward-looking statements express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance; they are not statements of historical facts and should not be viewed as any guarantee of any future result. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. The author and/or publisher of this report disclaims any obligation to update the forward-looking statements in this report, whether as a result of new information, future events, or results or otherwise. There is no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

The information provided in this report is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to applicable law or regulation, or would subject the author or publisher of this report to any registration requirement in such jurisdiction or country.

Information about the editor of this publication:
Juniorstocks.com is a service provided by Piccadilly Capital Group, Office 66, 101 Clapham High Street, London, SW4 7TB, UK. Piccadilly Capital Group is not the publisher of this report and was not paid for the publication of this report. Piccadilly Capital Group seeks to generate web traffic and a growing number of followers through the publication of articles or reports. Directors, officers, and other insiders of the publisher own an interest in Piccadilly Capital Group. Piccadilly Capital Group does not endorse or recommend the business, products, services, or securities of any company mentioned on www.juniorstocks.com. Piccadilly Capital Group will not share your information with any outside third parties. Due to the new data protection basic regulation, we ask you to read our data protection declaration carefully.

Note on copyright:
The contents published on this website and on connected media (e.g., e-mail, X, Facebook) are subject to applicable copyright and ancillary copyright laws. Any use not permitted by applicable copyright and ancillary copyright laws requires the prior written consent of the provider or the respective rights holder. In particular, this applies to the duplication, editing, translation, storage, processing, or reproduction of content in databases or other electronic media and systems. Contents and rights of third parties are marked as such. Unauthorized reproduction or transmission of individual contents or complete pages is not permitted and is punishable by law. Only the production of copies and downloads for personal, private, and non-commercial use is permitted. Links to the provider's website are always welcome and do not require the consent of the provider of the website. Photos and images on the website may not be shared unless the publisher itself has acquired the initial rights from authorized sources. The presentation of this website in external frames is only allowed with written permission. If you notice any violations, please inform us. Please note: The content of our articles, emails, or other publications or social networks such as X, LinkedIn or Facebook is exclusively intended for the designated addressee(s). If you are not the addressee of these articles, emails, or other publications in the market letter or social networks such as Twitter or Facebook or his or her legal representative, please note that any form of publication, reproduction, or distribution of the content of these articles, emails, or other publications in the market letter or social networks such as X, LinkedIn or Facebook is prohibited. Falsifications of the original content of this message during data transmission cannot be excluded in principle.